Storia in 2 fonti

Cardinal Health Sales Miss; Rival McKesson Near Buy Point

McKesson has the fastest growth among the three big drug distributors.

Raccontata da

investors.com

benzinga.com

Confronto fonti

2 prospettive sulla stessa storia

AI · summaries

investors.comStai leggendo3 g fa

Cardinal Health Sales Miss; Rival McKesson Near Buy Point

McKesson has the fastest growth among the three big drug distributors.

originale

benzinga.com3 g fa

Cardinal Health Stock Hits 52-Week High - Here's Why - Cardinal Health (NYSE:CAH)

Cardinal Health beat Q4 EPS ($2.91 vs $2.42) with 30% earnings growth, now exclusively serving ~50% of cell & gene therapy market. High-margin biotech logistics growth and new commercialization wins signal consolidation around infrastructure providers, validating Cardinal's specialty strategy.

Leggi questa versione → originale

Timeline cronologica

martedì 11 agosto 2026·investors.com
Why This Medical Stock Is Rising Despite Its Mixed Report
Cardinal Health stock rose slightly early Tuesday on better-than-expected fiscal fourth-quarter earnings, but sales missed.
martedì 11 agosto 2026·investors.com
Cardinal Health Sales Miss; Rival McKesson Near Buy Point
McKesson has the fastest growth among the three big drug distributors.

Cardinal Health Sales Miss; Rival McKesson Near Buy Point

Cardinal Health Stock Hits 52-Week High - Here's Why - Cardinal Health (NYSE:CAH)

Timeline cronologica

Why This Medical Stock Is Rising Despite Its Mixed Report

Cardinal Health Sales Miss; Rival McKesson Near Buy Point

Cardinal Health Stock Hits 52-Week High - Here's Why - Cardinal Health (NYSE:CAH)

Cardinal Health Analysts Increase Their Forecasts Following Q4 Results - Cardinal Health (NYSE:CAH)